Tag Archives: S&P Emerging ex-China BMI
China Equities Diverge from Developed and Emerging Markets
China, the world’s second-largest market by both GDP and stock market capitalization, is showing itself to be a worthy diversifier, with low correlations to other equity markets. While many developed and emerging stock market indices have traded more in sync since the onset of the COVID-19 pandemic, China has performed differently, with both domestic China…
- Categories Equities
- Other Tags
Safe Harbors and Silver Linings
As we reflect on this year’s notable market themes, one trend is certain: it has been a tumultuous market characterized by rate hikes and inflation concerns across regions, with significant losses across asset classes. Crypto market performance added to jitters, with the S&P Cryptocurrency LargeCap Index down 66% YTD. Losses throughout the year culminated in…
- Categories Equities, Fixed Income, S&P 500 & DJIA
- Other Tags
China A-Share Inclusion – An Update One Year Later
As we mark the one-year anniversary of the initial inclusion of China A-shares in S&P DJI’s global benchmarks, it seems an opportune time to provide an update on key developments relating to A-share inclusion and to examine the impact that A-shares have had on the composition and performance of the S&P Emerging BMI over the…
- Categories Equities
- Other Tags
- Categories
- Equities
- Other Tags
From COVID-19 to U.S.-China Tensions, What to Expect Next for Chinese Equities
On May 29, 2020, I joined S&P Global’s The Essential Podcast, “A View to the Future – China Beyond the Pandemic,” to discuss the Chinese equity market’s performance and the macroeconomic trends during and beyond the COVID-19 pandemic. This blog includes some key highlights we discussed, along with the related index performance observed in the…
- Categories Equities
- Other Tags